WASHINGTON – Senate Finance
Committee Chairman Chuck Grassley (R-Iowa) today released the following
statement regarding President Donald Trump’s executive orders on prescription
drug pricing.
“President
Trump continues to lead the way in the battle to lower prescription drug
prices, refusing to back down as Big Pharma fights reform at every turn. At the
beginning of this Congress, the CEOs of the world’s largest pharmaceutical
companies told the Finance Committee that they would be a part of the solution
and work with us to fix the problems plaguing the prescription drug pricing
system. Not only did they not follow through, they did everything in their
power to stop serious reforms.
“I
don’t blame President Trump for taking action on behalf of patients and all
Americans where Congress has failed. President Trump’s bold action contrasts
with Democrats’ refusal to work with Republicans to advance bipartisan
legislation. While Democrats play politics, President Trump is fighting for
patients.
“I’m
still reviewing the details of the executive orders to assess the implications
of these significant actions. There are some things I’ve expressed concern with
in the past. What is clear is that the coronavirus pandemic makes lowering
prescription drug prices all the more urgent. Cures and treatments can only
help beat this disease if they are affordable.
“President
Trump should be commended for his leadership. For those who don’t like
these executive actions, there’s time to get to the table and back a
legislative solution. I will continue the fight in Congress until
significant prescription drug pricing legislation becomes law. The next
coronavirus relief bill presents the perfect opportunity for Congress to meet
the moment.”